![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1673922
¹ÙÀÌ¿ÀĨ ½ÃÀå : Á¦Ç° À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°Biochips Market, By Product Type, By End User, By Geography |
¹ÙÀÌ¿ÀĨ ¼¼°è ½ÃÀåÀº 2025³â¿¡ 133¾ï 4,000¸¸ ´Þ·¯, 2032³â¿¡´Â 377¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ ¼ºÀå·ü(CAGR)Àº 16.0%¸¦ º¸ÀÏ Àü¸ÁÀÔ´Ï´Ù.
º¸°í ¹üÀ§ | º¸°í¼ »ó¼¼ ³»¿ë | ||
---|---|---|---|
±âÁØ ¿¬µµ | 2024³â | 2025³â ½ÃÀå ±Ô¸ð | 133¾ï 4,000¸¸ ´Þ·¯ |
½ÇÀû µ¥ÀÌÅÍ | 2020-2024³â | ¿¹Ãø ±â°£ | 2025-2032³â |
¿¹Ãø ±â°£(2025-2032³â) CAGR | 16.00% | 2032³â °¡Ä¡ ¿¹Ãø | 377¾ï 3,000¸¸ ´Þ·¯ |
¼¼°è ¹ÙÀÌ¿ÀĨ ½ÃÀåÀº º´¿øÃ¼ ¹× À¯ÀüÀÚ¿¡¼ ´Ü¹éÁú ¹× DNA ¿°±â¼¿¿¡ À̸£±â±îÁö »ý¹°ÇÐÀû ºÐÀÚÀÇ °ËÃâ ¹× ½Äº°¿¡ »ç¿ëµÇ´Â ±â¼ú·Î ±¸¼ºµÇ¾î ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿ÀĨÀº ½Å¾à°³¹ß, Áúº´ Áø´Ü, ½Äǰ ¾ÈÀü µî¿¡ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. Çõ½ÅÀûÀÎ ¹ÙÀÌ¿À¼¾¼ ±â¼ú °³¹ßÀ» À§ÇÑ Á¤ºÎ ¹× ¹Î°£ ±â°üÀÇ ¿¬±¸°³¹ß ³ë·Â°ú ÀÚ±Ý Áö¿ø Áõ°¡°¡ ½ÃÀå °³Ã´ÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ºÐÀÚ»ý¹°ÇÐ ºÐ¾ßÀÇ ¹ßÀü°ú Á¤¹ÐÀÇ·áÀÇ ºÎ»óÀ¸·Î »ê¾÷°è Àü¹Ý¿¡ °ÉÃÄ ¹ÙÀÌ¿ÀĨÀÇ Ã¤ÅÃÀÌ °¡¼Óȵǰí ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿ÀĨ ¼³°è ¹× Á¦Á¶ °øÁ¤ÀÇ °È´Â °¡±î¿î ¹Ì·¡¿¡ À¯¸®ÇÑ ¼ºÀå ±âȸ¸¦ °¡Á®¿Ã ¼ö ÀÖ½À´Ï´Ù.
¼¼°è ¹ÙÀÌ¿ÀĨ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº ¾Ï°ú °°Àº Áúº´ÀÇ À¯º´·ü Áõ°¡¿Í Á¶±â Áø´Ü¿¡ ´ëÇÑ °ü½ÉÀÔ´Ï´Ù. »ý¸í°øÇÐ ¹× »ý¸í°úÇÐ ¿¬±¸¿¡ ´ëÇÑ ÅõÀÚ È®´ëµµ »ýüºÐÀÚÀÇ »óÈ£ÀÛ¿ëÀ» Çö¹Ì°æ ¼öÁØ¿¡¼ °¨ÁöÇÏ´Â ¹ÙÀÌ¿ÀĨ¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ±×·¯³ª ¹ÙÀÌ¿ÀĨ °³¹ß¿¡´Â ³ôÀº ºñ¿ëÀÌ ¼Ò¿äµÇ¸ç, ¾ö°ÝÇÑ ±ÔÁ¦ ±âÁØÀº Á¦Ç° ½ÂÀÎÀ» Áö¿¬½Ãų ¼ö ÀÖ½À´Ï´Ù. ¼÷·ÃµÈ Àü¹®°¡ÀÇ ºÎÁ·Àº ¹ÙÀÌ¿ÀĨÀÇ º¸±ÞÀ» °¡·Î¸·°í ÀÖ½À´Ï´Ù. °³¹ßµµ»ó±¹¿¡´Â ¾ÆÁ÷ °³¹ßµÇÁö ¾ÊÀº ºñÁî´Ï½º ±âȸ°¡ ÀÖ½À´Ï´Ù. ¸¶ÀÌÅ©·Î¾î·¹ÀÌ¿Í ¸¶ÀÌÅ©·ÎÇ÷çÀ̵ñ½º ±â¼úÀÇ ÃâÇöÀº ¹ÙÀÌ¿ÀĨÀÇ °ËÃâ ´É·ÂÀ» Çâ»ó½Ã۰í, ÇコÄɾ¼ ȯ°æ ¸ð´ÏÅ͸µ ¹× ½Äǰ ¾ÈÀü °Ë»ç¿¡ À̸£±â±îÁö ÀÀ¿ë ºÐ¾ß¸¦ È®ÀåÇϰí ÀÖ½À´Ï´Ù.
¼¼°èÀÇ ¹ÙÀÌ¿ÀĨ ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇßÀ¸¸ç, 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2025-2032³â) ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
¶ÇÇÑ, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ °íÂûÀ» Á¦°øÇÕ´Ï´Ù.
ÀÌ º¸°í¼´Â ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ¹ÙÀÌ¿ÀĨ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
ÁÖ¿ä ±â¾÷À¸·Î´Â Illumina, Thermo Fisher Scientific Inc., Agilent Technologies, Bio-Rad Laboratories Inc. µîÀÌ ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼ÀÇ ÅëÂû·ÂÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
¹ÙÀÌ¿ÀĨ ¼¼°è ½ÃÀå º¸°í¼´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ¹ÙÀÌ¿ÀĨ ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ½±°Ô ³»¸± ¼ö ÀÖ½À´Ï´Ù.
Global Biochips Market is estimated to be valued at USD 13.34 Bn in 2025 and is expected to reach USD 37.73 Bn by 2032, growing at a compound annual growth rate (CAGR) of 16.0% from 2025 to 2032.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2024 | Market Size in 2025: | USD 13.34 Bn |
Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
Forecast Period 2025 to 2032 CAGR: | 16.00% | 2032 Value Projection: | USD 37.73 Bn |
Global biochips market consists of technology used for detecting and identifying biological molecules from pathogens and genes to proteins and DNA sequences. Biochips are used in drug discovery, disease diagnosis, and food safety, among others. Increasing R&D efforts and funding from governments and private organizations for developing innovative biosensor technologies can drive the market growth. Advancements in fields of molecular biology and rise of precision medicine have accelerated the adoption of biochips across industries. Enhancements in biochip design and manufacturing processes can offer lucrative growth opportunities in the near future.
Global biochips market growth is driven by rising prevalence of diseases like cancer and focus on early diagnosis. Growing investments in biotechnology and life science research also boosts demand for biochips to detect biomolecular interactions at microscopic levels. However, high costs associated with biochip development and strict regulatory norms can delay product approvals. Lack of skilled professionals can hamper its wider adoption. Untapped opportunities in developing nations present lucrative prospects. Emergence of microarray and microfluidic technology have improved detection capacities of biochips, thus, expanding application areas from healthcare to environmental monitoring and food safety testing.
This report provides in-depth analysis of the global biochips market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global biochips market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Illumina, Thermo Fisher Scientific Inc., Agilent Technologies, Bio-Rad Laboratories Inc., PerkinElmer Inc., Fluidigm Corporation, and GE Healthcare
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global biochips market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biochips market
Detailed Segmentation-